125 related articles for article (PubMed ID: 28550440)
1. CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis.
Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Tenorio-Pedraza JM; Hernández-Torre M
Acta Neurol Belg; 2017 Dec; 117(4):879-883. PubMed ID: 28550440
[TBL] [Abstract][Full Text] [Related]
2. Adipsin, MIP-1b, and IL-8 as CSF Biomarker Panels for ALS Diagnosis.
Gonzalez-Garza MT; Martinez HR; Cruz-Vega DE; Hernandez-Torre M; Moreno-Cuevas JE
Dis Markers; 2018; 2018():3023826. PubMed ID: 30405855
[TBL] [Abstract][Full Text] [Related]
3. Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study.
Hietaharju A; Kuusisto H; Nieminen R; Vuolteenaho K; Elovaara I; Moilanen E
Eur J Neurol; 2010 Feb; 17(2):332-4. PubMed ID: 19538214
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
8. Altered CSF cytokine network in amyotrophic lateral sclerosis patients: A pathway-based statistical analysis.
Martínez HR; Escamilla-Ocañas CE; Tenorio-Pedraza JM; Gómez-Almaguer D; Jaime-Perez JC; Olguín-Ramírez LA; Salazar-Marioni S; González-Garza MT
Cytokine; 2017 Feb; 90():1-5. PubMed ID: 27741429
[TBL] [Abstract][Full Text] [Related]
9. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis.
Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Moreno-Cuevas J; García Sarreón MA
Neurologia (Engl Ed); 2020 Apr; 35(3):165-169. PubMed ID: 29029824
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
Bossolasco P; Cancello R; Doretti A; Morelli C; Silani V; Cova L
J Neuroinflammation; 2017 Apr; 14(1):85. PubMed ID: 28427413
[TBL] [Abstract][Full Text] [Related]
11. Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.
Li JY; Cui LY; Sun XH; Shen DC; Yang XZ; Liu Q; Liu MS
Ann Clin Transl Neurol; 2022 Jul; 9(7):1027-1038. PubMed ID: 35584112
[TBL] [Abstract][Full Text] [Related]
12. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.
Drannik A; Martin J; Peterson R; Ma X; Jiang F; Turnbull J
PLoS One; 2017; 12(2):e0171668. PubMed ID: 28170441
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
17. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
[TBL] [Abstract][Full Text] [Related]
18. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
[TBL] [Abstract][Full Text] [Related]
20. Significance of CSF NfL and tau in ALS.
Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
